MAMaha Alhoda

Maha Alhoda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maha Alhoda has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ethnic and Racial Variations in Thyroid Eye Disease: Clinical Features and Management

    by Fatema M.A. Aljufairi, Fatema A. Almenow, Maha Alhoda, Kenneth Ka Hei Lai, Clement Chee Yung Tham, Chi Pui Pang, Kelvin Kam Lung Chong

    Background: Thyroid eye disease (TED) is an autoimmune orbital disorder with a broad clinical spectrum, ranging from mild symptoms to sight-threatening complications. Increasing evidence demonstrates variation in disease presentation and severity across populations, with implications for diagnosis and management. Methods: This narrative review synthesizes published literature from PubMed, Web of Science, MEDLINE (via EBSCOhost and Ovid), and the Cochrane Library to examine ethnic and racial differences in the epidemiology, orbital anatomy, clinical phenotype, immunologic profile, diagnosis, and management of TED across diverse populations. Results: Female predominance is highest in African and Western populations and lower in Asian cohorts, while thyroid status varies most in South Asia. Smoking rates are higher in Western populations and lower in South Asian and African cohorts. Asian populations more commonly exhibit muscle-predominant disease with increased risk of apical crowding, whereas Western populations more frequently present with prominent proptosis and eyelid signs; South Asian and Middle Eastern populations show more variable patterns. Inflammatory activity is often low at presentation, although a “low-CAS progressive” phenotype has been described in Asian cohorts. TRAb positivity is consistently high across populations, but is highest in South Asian cohorts. Diagnostic interpretation is influenced by population-specific anatomic differences and limitations of standard assessment tools. Management varies by region, with greater reliance on antithyroid medications in Asian and African populations and wider access to advanced therapies in Western settings. Conclusion: Ethnic differences in TED have important clinical implications. Population-specific interpretation of clinical findings is essential, as standard assessment tools may not fully reflect disease severity.

  • Open Access

    Diagnostic Limitations, Patient Characteristics, and Confounding Factors Impacting Neurotologic Lesion Imaging: A Systematic Review

    by Diana Hamdan, Precious Ochuwa Imokhai, Alexandra Konvalina, BaoKhanh Nguyen, Maha Alhoda, Valentina Alejandra Da Silva Acosta, Waseem Syed, Amanda Brooks

    Background: Neuroimaging protocols for neurotologic disease are often developed without consideration of patient-specific factors such as biological differences, clinical presentation variability, and comorbidities. This lack of tailored design contributes to insufficient detection, delayed diagnosis, and inappropriate treatment. Objectives: To critically examine the literature on diagnostic limitations of neuroimaging for neurotologic lesions and identify gaps in protocol validation, accuracy, and clinical translation. Methods: A systematic review of PubMed and Google Scholar was conducted, focusing on studies published between 2015 and 2025 that evaluated diagnostic imaging outcomes in patients with neurotologic lesions. Eligible studies included prospective cohorts, retrospective analyses, and consensus statements. Outcomes of interest included the sensitivity and specificity of imaging modalities, prevalence of misdiagnosis, and the influence of biological, anatomical, and clinical variability on diagnostic performance. Results: The literature demonstrates that neurotologic disorders are frequently associated with diagnostic challenges, including atypical clinical presentations, overlapping symptoms, and stroke mimics, which complicate image interpretation. Standard magnetic resonance imaging (MRI) protocols often miss subtle or early ischemic changes, resulting in delayed intervention. Few studies stratify outcomes by patient characteristics, and most protocols were developed in generalized populations without comprehensive validation. Evidence on advanced imaging modalities (positron emission tomography (PET), single-photon emission computed tomography (SPECT), high-resolution MRI) remains limited, and large-scale prospective studies addressing diagnostic accuracy gaps are lacking. In summary, a total of 27 studies met inclusion criteria. Conclusions: Current neuroimaging methods are insufficiently validated across diverse patient populations, contributing to the underdiagnosis and mismanagement of neurotologic disease. Improved diagnostic accuracy will require large-scale, prospective research, standardized outcome reporting, and imaging protocols designed to account for patient-specific variability.